NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium

Description

This document in this compendium was contributed by the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium which is part of the Rare Diseases Clinical Research Network (RDCRN; https://www.rarediseasesnetwork.org/). RDCRN is focused on therapeutic developments for amyotrophic lateral sclerosis, frontotemporal dementia, primary lateral sclerosis, hereditary spastic paraplegia, and progressive muscular atrophy. This SOP is available from https://www.rarediseasesnetwork.org/cms/create/researchers/biorepository.

Sources

  • CReATe

SOPs

Title Version (Release Date) Source
BIOSPECIMEN COLLECTION SOP CReATe
Download all SOP documents of selected versions [1]
comments powered by Disqus

News and Announcements

  • The Most Downloaded SOPs in 2022

  • New Findings from NCI's BPV Program have been Published

  • New SOPs were Recently Added to the BRD SOP Library

  • More...